Patent Assignment
Reel/Frame 044574/0912
Assignment of Assignor's Interest
Recorded: 2018-01-09
Pages: 7
Assignors
VON MALTZAHN, GEOFFREY A.
Executed: 2016-01-13
YAMANAKA, YVONNE J.
Executed: 2016-01-13
MILWID, JOHN MILES
Executed: 2016-01-13
Assignee
FLAGSHIP VENTURES MANAGEMENT, INC.
1 MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Glycan Therapeutics for Reducing Blood Ammonia
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 9, 2018
From: FLAGSHIP VENTURES MANAGEMENT, INC.
To: KALEIDO BIOSCIENCES, INC.
Reel/Frame 044574/0978 →
Assignment of Assignor's Interest
Jan 9, 2018
From: GEREMIA, JOHN M.
To: MIDORI USA, INC.
Reel/Frame 044575/0007 →
Assignment of Assignor's Interest
Jan 9, 2018
From: MIDORI USA, INC.
To: KALEIDO BIOSCIENCES, INC.
Reel/Frame 044575/0035 →
Assignment of Assignor's Interest
Jan 9, 2018
From: SILVERMAN, JARED A.
To: KALEIDO BIOSCIENCES, INC.
Reel/Frame 044575/0085 →
Assignment of Assignor's Interest
Sep 9, 2022
From: KALEIDO BIOSCIENCES, INC.; CARDENA BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 061404/0320 →
Assignment of Assignor's Interest
Sep 10, 2022
From: HERCULES CAPITAL, INC.
To: DSM NUTRITIONAL PRODUCTS, LLC
Reel/Frame 061362/0001 →
Corrective Assignment to Correct the the Second Assignor Name Previously Recorded at Reel: 061404 Frame: 0320. Assignor(S) Hereby Confirms the Assignment.
Oct 18, 2022
From: KALEIDO BIOSCIENCES, INC.; CADENA BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 061700/0414 →